EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Open Access
- 1 July 2018
- journal article
- research article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 69 (1), 182-236
- https://doi.org/10.1016/j.jhep.2018.03.019
Abstract
No abstract availableKeywords
This publication has 616 references indexed in Scilit:
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinomaEuropean Journal of Cancer, 2012
- Management of hepatocellular carcinoma: An updateJournal of Hepatology, 2011
- Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiography-assisted CT) with special reference to multi-step hepatocarcinogenesisAbdominal Radiology, 2011
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V StudyCardioVascular and Interventional Radiology, 2009
- Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: A meta-analysisJournal of Hepatology, 2009
- Validation of the BCLC Prognostic System in Surgical Hepatocellular Cancer PatientsTransplantation Proceedings, 2009
- Trends in mortality from hepatocellular carcinoma in Europe, 1980‐2004Journal of Hepatology, 2008
- Coffee drinking and hepatocellular carcinoma risk: A meta-analysisJournal of Hepatology, 2007
- Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosisJournal of Hepatology, 2006
- Randomized controlled trial of screening for hepatocellular carcinomaZeitschrift für Krebsforschung und Klinische Onkologie, 2004